Beta-blockers, the gold standard drug treatment for heart attacks, is ineffective for many and may increase the risk of death and disability in certain women, new studies find.

Experts released a new clinical guideline for effectively managing individuals diagnosed with hypertrophic cardiomyopathy (HCM). The guideline reiterates the importance of collaborative ...

Bristol Myers Squibb BMY suffered a setback in the late-stage ODYSSEY-HCM study evaluating cardiovascular drug Camzyos (mavacamten). The phase III study was evaluating Camzyos for the treatment of ...

Conducted across seven U.S. health systems including Duke University Health System, Cleveland Clinic, and Ascension St. Vincent, VITAL-HF enrolled 178 adults with HFrEF who were not yet optimized on ...

This little pill — taken by adults and children alike — might just be a prescription for heart disease. Speaking to The Post, the veteran heart doctor tackled a drug that is commonly prescribed to ...

Described by the NHS as an anaesthetic drug and commonly used by vets on animals, ketamine is currently classified as a Class B drug by the government. Cannabis, codeine and amphetamines are also in ...

Tourmaline licensed the atherosclerotic cardiovascular disease drug pacibekitug from Pfizer, which remains eligible for milestone payments tied to the progress of the drug.

Drug Farm, Cincinnati Children’s Collaborate on DF-003 as Potential Therapy for Heart Disease and Blood Cancers ...